New Zealand vs Trinidad and Tobago: New or unknown treatment history cases: Pulmonary, bacteriologically
New Zealand
147
in 2023
Trinidad and Tobago
154
in 2023
New Zealand rank
148th
Trinidad and Tobago rank
146th
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- New Zealand
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 154 against 147 in New Zealand, a difference of 7.
The two have swapped places 2 times across 11 shared years of data; in 2013 it was Trinidad and Tobago ahead.
New Zealand ranks 148th and Trinidad and Tobago ranks 146th of 197 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Zealand | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 153.14 | 131.86 | 21.29 | New Zealand |
| 2020s | 147.75 | 128 | 19.75 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, New Zealand or Trinidad and Tobago?
- Trinidad and Tobago, at 154 against 147 in New Zealand as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between New Zealand and Trinidad and Tobago?
- 7, with Trinidad and Tobago ahead.
- How many years of comparable data are there for New Zealand and Trinidad and Tobago?
- 11 years are reported by both, from 2013 to 2023.
- How do New Zealand and Trinidad and Tobago rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- New Zealand ranks 148th and Trinidad and Tobago ranks 146th of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.